Mesenchymal Stem Cell Therapy Trial for Multiple Sclerosis – eMaxHealth
eMaxHealth |
Mesenchymal Stem Cell Therapy Trial for Multiple Sclerosis
eMaxHealth The first Canadian clinical trial to explore mesenchymal stem cell therapy for multiple sclerosis is now underway with the help of a $4.2 million grant. This groundbreaking effort is under the direction of Mark S. Freedman, MD, of the University of … |
